LY-344864

LY-344864
Identifiers
	IUPAC name N-[(6R)-6-(dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide;
CAS Number	186544-26-3;
PubChem CID	5311097;
CompTox Dashboard (EPA)	DTXSID201134040 ;
Chemical and physical data
Formula	C21H22FN3O
Molar mass	351.425 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CN(C)[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)NC(=O)C4=CC=C(C=C4)F;
	InChI InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26)/t16-/m1/s1; Key:GKWHICIUSVVNGX-MRXNPFEDSA-N;

LY-344,864 is an experimental drug that is a cyclised derivative from the substituted tryptamine family, which acts as an agonist for the 5-HT_1F serotonin receptor.^[1] It has anti-migraine activity in animal models but was never developed for this indication as a medicine,^[2]^[3] however it continues to be used in scientific research and in recent years has been investigated as a potential agent for stimulating mitochondrial biogenesis, which can facilitate repair to damaged cells and tissues with a number of potential medical applications.^[4]^[5]^[6]^[7]^[8]

References

^ Phebus LA, Johnson KW, Zgombick JM, Gilbert PJ, Van Belle K, Mancuso V, et al. (1997). "Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine". Life Sciences. 61 (21): 2117–2126. doi:10.1016/s0024-3205(97)00885-0. PMID 9395253.
^ Mitsikostas DD, Tfelt-Hansen P (December 2012). "Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future". Central Nervous System Agents in Medicinal Chemistry. 12 (4): 241–249. doi:10.2174/187152412803760627. PMID 22934751.
^ Mitsikostas DD, Waeber C, Sanchez-Del-Rio M, Raffaelli B, Ashina H, Maassen van den Brink A, et al. (August 2023). "The 5-HT_1F receptor as the target of ditans in migraine - from bench to bedside". Nature Reviews. Neurology. 19 (8): 489–505. doi:10.1038/s41582-023-00842-x. PMID 37438431.
^ Garrett SM, Whitaker RM, Beeson CC, Schnellmann RG (August 2014). "Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury". The Journal of Pharmacology and Experimental Therapeutics. 350 (2): 257–264. doi:10.1124/jpet.114.214700. PMC 4109485. PMID 24849926.
^ Scholpa NE, Lynn MK, Corum D, Boger HA, Schnellmann RG (January 2018). "5-HT_1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease". British Journal of Pharmacology. 175 (2): 348–358. doi:10.1111/bph.14076. PMID 29057453.
^ Shahidi S, Sadeghian R, Komaki A, Asl SS (October 2018). "Intracerebroventricular microinjection of the 5-HT_1F receptor agonist LY 344864 inhibits methamphetamine conditioned place preference reinstatement in rats". Pharmacology, Biochemistry, and Behavior. 173: 27–35. doi:10.1016/j.pbb.2018.08.001. PMID 30077744.
^ Dupre TV, Jenkins DP, Muise-Helmericks RC, Schnellmann RG (November 2019). "The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells". Biochemical Pharmacology. 169: 113644. doi:10.1016/j.bcp.2019.113644. PMID 31542386.
^ Simmons EC, Scholpa NE, Cleveland KH, Schnellmann RG (February 2020). "5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury". The Journal of Pharmacology and Experimental Therapeutics. 372 (2): 216–223. doi:10.1124/jpet.119.262410. PMID 31776207.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] Phebus LA, Johnson KW, Zgombick JM, Gilbert PJ, Van Belle K, Mancuso V, et al. (1997). "Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine". Life Sciences. 61 (21): 2117–2126. doi:10.1016/s0024-3205(97)00885-0. PMID 9395253.

[2] Mitsikostas DD, Tfelt-Hansen P (December 2012). "Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future". Central Nervous System Agents in Medicinal Chemistry. 12 (4): 241–249. doi:10.2174/187152412803760627. PMID 22934751.

[3] Mitsikostas DD, Waeber C, Sanchez-Del-Rio M, Raffaelli B, Ashina H, Maassen van den Brink A, et al. (August 2023). "The 5-HT_1F receptor as the target of ditans in migraine - from bench to bedside". Nature Reviews. Neurology. 19 (8): 489–505. doi:10.1038/s41582-023-00842-x. PMID 37438431.

[4] Garrett SM, Whitaker RM, Beeson CC, Schnellmann RG (August 2014). "Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury". The Journal of Pharmacology and Experimental Therapeutics. 350 (2): 257–264. doi:10.1124/jpet.114.214700. PMC 4109485. PMID 24849926.

[5] Scholpa NE, Lynn MK, Corum D, Boger HA, Schnellmann RG (January 2018). "5-HT_1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease". British Journal of Pharmacology. 175 (2): 348–358. doi:10.1111/bph.14076. PMID 29057453.

[6] Shahidi S, Sadeghian R, Komaki A, Asl SS (October 2018). "Intracerebroventricular microinjection of the 5-HT_1F receptor agonist LY 344864 inhibits methamphetamine conditioned place preference reinstatement in rats". Pharmacology, Biochemistry, and Behavior. 173: 27–35. doi:10.1016/j.pbb.2018.08.001. PMID 30077744.

[7] Dupre TV, Jenkins DP, Muise-Helmericks RC, Schnellmann RG (November 2019). "The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells". Biochemical Pharmacology. 169: 113644. doi:10.1016/j.bcp.2019.113644. PMID 31542386.

[8] Simmons EC, Scholpa NE, Cleveland KH, Schnellmann RG (February 2020). "5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury". The Journal of Pharmacology and Experimental Therapeutics. 372 (2): 216–223. doi:10.1124/jpet.119.262410. PMID 31776207.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]